VNDA icon

Vanda Pharmaceuticals
VNDA

Overview Fund Activity

137 hedge funds and large institutions have $711M invested in Vanda Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 51 increasing their positions, 40 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
137
Holders Change
+4
Holders Change %
+3.01%
% of All Funds
3.42%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
20
Increased
51
Reduced
40
Closed
15
Calls
$6.47M
Puts
$1.16M
Net Calls
+$5.31M
Net Calls Change
+$3.92M

Top Buyers

1
RCAMU
1
Rothschild & Co Asset Management US
Connecticut
$23.5M
2
Millennium Management
2
Millennium Management
New York
$25.8M
3
BBA
3
Baker Bros. Advisors
New York
$7.59M
4
Invesco
4
Invesco
Georgia
$7.34M
5
BIM
5
Bogle Investment Management
Massachusetts
$6.31M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$1.79M
2
GPP
2
Great Point Partners
Connecticut
$8.91M
3
AC
3
Armistice Capital
New York
$27.4M
4
NC
4
Nexthera Capital
New York
$0
5
SCM
5
Stonepine Capital Management
Oregon
$5.37M
Name Holding Trade Value Shares
Change 		Shares
Change %
KF
151
Krilogy Financial
Missouri
– -$3K -200 Closed
3 4 5 6
7